French drugmaker Sanofi SA (NASDAQ:SNY) on Monday said it is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus ...

Sanofi boosts Beyfortus output for RSV season while Dupixent trial shows strong eczema relief in patients with skin of color.

Richard Childress Racing in the NASCAR Cup Series at the Chicago Street Race… NASCAR returns to Chicago for the sport’s only street race, which weaves through Chicago’s Grant Park area, artfully ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic ...

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.

AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases. The drugmaker will collaborate with CSPC ...

AstraZeneca said it entered into a strategic research collaboration with China’s CSPC Pharmaceuticals, focused on artificial intelligence-driven research, valued at up to $5.33 billion.

AstraZeneca partners with CSPC to accelerate AI-powered small molecule drug discovery, targeting chronic diseases with novel oral therapies developed in China. The collaboration expands AstraZeneca's ...

According to Benzinga Pro, AstraZeneca's peer group average for short interest as a percentage of float is 3.86%, which means the company has less short interest than most of its peers.

One of the most popular gaming YouTubers is named Bloo, but he isn’t a human — he’s a fully virtual personality powered by ...

A new blood test uses what is known as biomarkers to identify a person’s Alzheimer’s disease status, changing how we monitor ...